Clonidine improves hyperarousal in borderline personality disorder with or without comorbid posttraumatic stress disorder: A randomized, double-blind, placebo-controlled trial

Journal of Clinical Psychopharmacology

Volumn 29, Issue 2, 2009, Pages 170-173

  Ziegenhorn, Andreas A ^a,b,c   Roepke, Stefan ^a   Schommer, Nicole C ^a   Merkl, Angela ^a   Danker Hopfe, Heidi ^a   Perschel, Frank H ^a   Heuser, Isabella ^a   Anghelescu, Ion G ^a   Lammers, Claas H ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Hôtel Dieu Hospital   (Canada)

^c Hôtel Dieu de St Jérôme ^*  (Canada)

Author keywords

Borderline personality disorder; Hyperarousal; Pharmacotherapy; Randomized contolled trial

Indexed keywords

ADRENALIN; CLONIDINE; DOPAMINE; NORADRENALIN; PLACEBO;

ADRENALIN URINE LEVEL; ADULT; ANKLE EDEMA; ARTICLE; BORDERLINE STATE; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOPAMINE URINE LEVEL; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; DRUG MECHANISM; EVENING DOSAGE; FATIGUE; FEMALE; HUMAN; HYPERAROUSAL SYNDROME; MALE; MORNING DOSAGE; MORNING TIREDNESS; NORADRENALIN URINE LEVEL; ORTHOSTATIC HYPOTENSION; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLEEP AROUSAL DISORDER; TREATMENT OUTCOME; TREATMENT RESPONSE; XEROSTOMIA;

ADRENERGIC ALPHA-AGONISTS; ADULT; AROUSAL; BORDERLINE PERSONALITY DISORDER; CLONIDINE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PILOT PROJECTS; PSYCHOMETRICS; SEVERITY OF ILLNESS INDEX; SLEEP DISORDERS; STRESS DISORDERS, POST-TRAUMATIC; YOUNG ADULT;

EID: 67649331672     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31819a4bae     Document Type: Article

References (28)

1. Lieb K, Zanarini MC, Schmahl C, et al. Borderline personality disorder. Lancet. 2004;364 (9432):453-461.
2. Oldham JM, Gabbard GO, Goin MK, et al. Practice guideline for the treatment of patients with borderline personality disorder. American Psychiatric Association. Am J Psychiatry. 2001;158(10 suppl):1-52.
3. Zanarini MC, Frankenburg FR, Hennen J, et al. Axis I comorbidity in patients with borderline personality disorder: 6-year follow-up and prediction of time to remission. Am J Psychiatry. 2004; 161(11): 2108-2114.
4. McGlashan TH, Grilo CM, Skodol AE, et al. The Collaborative Longitudinal Personality Disorders Study: baseline Axis I/II and II/II diagnostic co-occurrence. Acta Psychiatr Scand. 2000; 102(4): 256-264.
5. Zlotnick C, Johnson DM, Yen S, et al. Clinical features and impairment in women with borderline personality disorder (BPD) with posttraumatic stress disorder (PTSD), BPD without PTSD, and other personality disorders with PTSD. J Nerv Ment Dis. 2003;191(11): 706-713.
6. Gunderson JG, Sabo AN. The phenomenological and conceptual interface between borderline personality disorder and PTSD. Am J Psychiatry. 1993;150(1):19-27.
7. Schmahl C, Bohus M. Symptom-focussed drug therapy in borderline personality disorder. Fortschr Neurol Psychiatr. 2001;69(7):310-321.
8. Stiglmayr CE, Grathwol T, Linehan MM, et al. Aversive tension in patients with borderline personality disorder: a computer-based controlled field study. Acta Psychiatr Scand. 2005;111(5):372-379.
9. Ebner-Priemer UW, Kuo J, Kleindienst N, et al. State affective instability in borderline personality disorder assessed by ambulatory monitoring. Psychol Med. 2007;37(7):961-970.
10. Gurvits IG, Koenigsberg HW, Siever LJ. Neurotransmitter dysfunction in patients with borderline personality disorder. Psychiatr Clin North Am. 2000;23(1):27-40.
11. Raskind MA, Peskind ER, Hoff DJ, et al. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder. Biol Psychiatry. 2007;61:928-934.
12. Raskind MA, Peskind ER, Kanter ED, et al. Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study. Am J Psychiatry. 2003;160(2):371-373.
13. Philipsen A, Richter H, Schmahl C, et al. Clonidine in acute aversive inner tension and self-injurious behavior in female patients with borderline personality disorder. J Clin Psychiatry. 2004;65(10): 1414-1419.
14. Schnyder U, Moergeli H. German version of clinician-administered PTSD scale. J Trauma Stress. 2002;15(6):487-492.
15. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(suppl 20):22-33.
16. First MB, Gibbon M, Spitzer RL, et al. Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II). Washington, DC: American Psychiatric Press; 1997.
17. Bohus M, Limberger MF, Frank U, et al. Psychometric properties of the Borderline Symptom List (BSL). Psychopathology. 2007;40(2): 126-132.
18. Hoffmann RM, Müller T, Hajak G, et al. Sleep logs in sleep research and sleep medicine. Somnologie. 1997;1(3):103-109.
19. Schmitz N, Hartkamp N, Kiuse J, et al. The Symptom Check-List-90-R (SCL-90-R): a German validation study. Qual Life Res. 2000;9(2): 185-193.
20. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
21. Boehnlein JK, Kinzie JD. Pharmacologic reduction of CNS noradrenergic activity in PTSD: the case for clonidine and prazosin. J Psychiatr Pract. 2007;13(2):72-78.
22. Strawn JR, Geracioti TD Jr. Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder. Depress Anxiety. 2008;25(3):260-271.
23. Southwick SM, Bremner JD, Rasmusson A, et al. Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder. Biol Psychiatry. 1999;46(9):1192-1204.
24. Herpertz SC, Dietrich TM, Wenning B, et al. Evidence of abnormal amygdala functioning in borderline personality disorder: a functional MRI study. Biol Psychiatry. 2001;50(4):292-298.
25. Donegan NH, Sanislow CA, Blumberg HP, et al. Amygdala hyperreactivity in borderline personality disorder: implications for emotional dysregulation. Biol Psychiatry. 2003;54(11):1284-1293.
26. Shin LM, Rauch SL, Pitman RK. Amygdala, medial prefrontal cortex, and hippocampal function in PTSD. Ann N Y Acad Sci. 2006;1071:67-79.
27. O'Donnell T, Hegadoren KM, Coupland NC. Noradrenergic mechanisms in the pathophysiology of post-traumatic stress disorder. Neuropsychobiology. 2004;50(4):273-283.
28. Zanarini MC, Williams A A, Lewis RE, et al. Reported pathological childhood experiences associated with the development of borderline personality disorder. Am J Psychiatry. 1997;154(8):1101-1106.